Jiang S, Li C, Liu D, Zeng F, Wei W, He T
Oncol Lett. 2025; 29(4):166.
PMID: 39963320
PMC: 11831725.
DOI: 10.3892/ol.2025.14912.
Engin A
Adv Exp Med Biol. 2024; 1460:767-819.
PMID: 39287872
DOI: 10.1007/978-3-031-63657-8_26.
Bloise N, Giannaccari M, Guagliano G, Peluso E, Restivo E, Strada S
Cells. 2024; 13(12.
PMID: 38920683
PMC: 11201503.
DOI: 10.3390/cells13121054.
Wu X, Wang S, Lin L, Jia X, Hu C, Qi H
Front Endocrinol (Lausanne). 2024; 15:1321622.
PMID: 38904041
PMC: 11186986.
DOI: 10.3389/fendo.2024.1321622.
Schindler E, Takita C, Collado-Mesa F, Reis I, Zhao W, Yang G
BMC Womens Health. 2024; 24(1):312.
PMID: 38816709
PMC: 11138080.
DOI: 10.1186/s12905-024-03020-3.
The elusive Luminal B breast cancer and the mysterious chemokines.
de Araujo R, da Luz F, da Costa Marinho E, Nascimento C, Mendes T, Mosca E
J Cancer Res Clin Oncol. 2023; 149(14):12807-12819.
PMID: 37458802
DOI: 10.1007/s00432-023-05094-2.
BUN level is associated with cancer prevalence.
Wang C, Sun H, Liu J
Eur J Med Res. 2023; 28(1):213.
PMID: 37393332
PMC: 10314395.
DOI: 10.1186/s40001-023-01186-4.
The role of autophagy in regulating metabolism in the tumor microenvironment.
Zhang P, Cheng S, Sheng X, Dai H, He K, Du Y
Genes Dis. 2023; 10(2):447-456.
PMID: 37223500
PMC: 10201556.
DOI: 10.1016/j.gendis.2021.10.010.
Targeting adipocyte-immune cell crosstalk to control breast cancer progression.
Wang W, Chen H, Yin S, Yang Z, Zhang F
J Cancer Res Clin Oncol. 2023; 149(10):7969-7979.
PMID: 36914785
DOI: 10.1007/s00432-023-04685-3.
Remodeling tumor microenvironment with natural products to overcome drug resistance.
Zhang W, Li S, Li C, Li T, Huang Y
Front Immunol. 2022; 13:1051998.
PMID: 36439106
PMC: 9685561.
DOI: 10.3389/fimmu.2022.1051998.
Crosstalk between Depression and Breast Cancer via Hepatic Epoxide Metabolism: A Central Comorbidity Mechanism.
Ye Z, Ganesan K, Wu M, Hu Y, She Y, Tian Q
Molecules. 2022; 27(21).
PMID: 36364213
PMC: 9655600.
DOI: 10.3390/molecules27217269.
Reversing the Genomic, Epigenetic, and Triple-Negative Breast Cancer-Enhancing Effects of Obesity.
Bowers L, Doerstling S, Shamsunder M, Lineberger C, Rossi E, Montgomery S
Cancer Prev Res (Phila). 2022; 15(9):581-594.
PMID: 35696725
PMC: 9444913.
DOI: 10.1158/1940-6207.CAPR-22-0113.
In Silico Analysis of Ion Channels and Their Correlation with Epithelial to Mesenchymal Transition in Breast Cancer.
Parthasarathi K, Mandal S, Singh S, Gundimeda S, Jolly M, Pandey A
Cancers (Basel). 2022; 14(6).
PMID: 35326596
PMC: 8946083.
DOI: 10.3390/cancers14061444.
The Obesity-Related Metabolic Gene HSD17B8 Protects Against Breast Cancer: High RNA/Protein Expression Means a Better Prognosis.
Nie Y, Huang F, Lou L, Yan J
Med Sci Monit. 2022; 28:e934424.
PMID: 35184130
PMC: 8876026.
DOI: 10.12659/MSM.934424.
Identification and validation of plasma biomarkers for diagnosis of breast cancer in South Asian women.
Rajkumar T, Amritha S, Sridevi V, Gopal G, Sabitha K, Shirley S
Sci Rep. 2022; 12(1):100.
PMID: 34997107
PMC: 8742108.
DOI: 10.1038/s41598-021-04176-w.
Radioresistance of Human Cancers: Clinical Implications of Genetic Expression Signatures.
de Mey S, Dufait I, De Ridder M
Front Oncol. 2021; 11:761901.
PMID: 34778082
PMC: 8579106.
DOI: 10.3389/fonc.2021.761901.
Adipocytic Glutamine Synthetase Upregulation Altered Histone Methylation Promotes 5FU Chemoresistance in Peritoneal Carcinomatosis of Colorectal Cancer.
Zhang X, Li Q, Du A, Li Y, Shi Q, Chen Y
Front Oncol. 2021; 11:748730.
PMID: 34712612
PMC: 8547656.
DOI: 10.3389/fonc.2021.748730.
ZNF217: the cerberus who fails to guard the gateway to lethal malignancy.
Li Y, Wu H, Wang Q, Xu S
Am J Cancer Res. 2021; 11(7):3378-3405.
PMID: 34354851
PMC: 8332857.
Variation of Long Non-Coding RNA And mRNA Profiles in Breast Cancer Cells With Influences of Adipocytes.
Cao X, Yang K, Liang M, Ma P, Xu D, Fei Y
Front Oncol. 2021; 11:631551.
PMID: 34094912
PMC: 8176020.
DOI: 10.3389/fonc.2021.631551.
Natural and Synthetic PPARγ Ligands in Tumor Microenvironment: A New Potential Strategy against Breast Cancer.
Augimeri G, Gelsomino L, Plastina P, Giordano C, Barone I, Catalano S
Int J Mol Sci. 2020; 21(24).
PMID: 33352766
PMC: 7767156.
DOI: 10.3390/ijms21249721.